Pioneering
possibility.
Maverick Bio is an independent, Australian-owned biomaterials technology and manufacturing company. We source, develop and manufacture naturally derived biomaterials for medical device, pharmaceutical and biotechnology teams, from early development through commercial supply.
To save and improve lives around the world.
The people we work with build the devices, therapies and tests that reach patients. Every material we supply ends up somewhere that matters. That shapes how we source, control and document it, and how quickly we respond.
Helping move programstoward market.
Maverick built its reputation on sourcing, selecting, preparing and documenting material around each customer’s process. Today, we also support supply planning from bench to commercial scale and develop biomaterial technologies for partners to take to market.

Trust
Long-standing relationships and a record of delivering for customers.

Expertise
Deep knowledge of biological materials, regulatory requirements and commercialisation.

Control
Hands-on involvement from origin through preparation and supply

Partnership
Working alongside customers on complex material, development and supply challenges.
Start where the
risk is lowest.
Australia and New Zealand are recognised by the World Organisation for Animal Health as negligible BSE risk, and BSE has never been detected in cattle in either country. For teams working under animal tissue regulations, that origin provides a stronger starting point.
Austrailia
Canada
China
Germany
India
Israel
Italy
Mexico
New Zealand
Ireland
South Korea
Switzerland
Taiwan
Thailand
USA
Belgium
Japan
UK
What guides
the work.
Our values shape how we approach materials, partnerships and every decision along the way. They keep us curious, accountable and focused on work that can make a meaningful difference.

Professor Thomas Cox
Extracellular matrix biology and cancer research.

Dr Marco Domingos
3D bioprinting, advanced biomaterials and regenerative medicine.

Dr Terance Hart
Collagen biomaterials, pharmaceutical development and clinical translation.

Paul Broadfoot
Technology commercialisation and business growth.
.webp)
Vanessa Worsfold
Medical device development, regulatory strategy and commercialisation.






